Thousands of people in Britain are suing the health care giant Johnson & Johnson over claims that the company’s baby powder caused cancer, mirroring a long-running litigation battle in the United States over the talc-based product.
More than 3,000 people have joined the lawsuit, which was filed in Britain’s High Court on Tuesday. The initial value of the claim is 1 billion pounds ($1.3 billion), said KP Law, which filed the case on behalf of the individuals. It is the first group claim against the company in Britain.
The claimants allege that from 1965 to 2023, Johnson & Johnson sold talc products, which it knew contained carcinogenic fibers, including asbestos, in pursuit of profits. The company stopped selling talc-based baby powder in the United States and Canada in 2020, switching to cornstarch, which it adopted globally in 2023.
The claims in Britain are similar to others made in the United States, where the company has faced accusations from tens of thousands of people. Last week, Johnson & Johnson was ordered by a Los Angeles jury to pay $966 million to the family of a California woman who died from a rare and aggressive cancer. This year, the company’s request to use a bankruptcy court for a $9 billion settlement to resolve around 70,000 claims was rejected.
For decades, Johnson & Johnson’s baby powder was made from the mineral talc. The company has spent years claiming that the product is safe. Internal memos have shown, however, that the company had long been concerned that talc could be contaminated with asbestos, a known carcinogen that often appears underground near talc.
In 2023, Johnson & Johnson spun off its consumer brands to a stand-alone company called Kenvue. “We sympathize deeply with people living with cancer,” Kenvue said in a statement on Thursday.
Kenvue defended the safety of baby powder, saying it is “backed by years of testing” by laboratories, universities and health authorities around the world. The talc used in baby power “was compliant with any required regulatory standards, did not contain asbestos and does not cause cancer.”
The legal action in Britain includes people who developed diseases including ovarian cancer and mesothelioma, a type of cancer linked to asbestos exposure. They say they were exposed to the product for at least five years, during infancy and childhood and sometimes continuing into adulthood.
The claim says that baby powder was marketed in Britain with packaging that said it was “mildness clinically proven.”
“For decades, Johnson & Johnson have orchestrated a campaign of denials and subterfuge,” Tom Longstaff, a partner at KP Law, said in a statement. “We will be relentless in holding them to account on behalf of all those who have suffered due to their actions.”
Eshe Nelson is a Times reporter based in London, covering economics and business news.
The post Johnson & Johnson Sued in U.K. Over Baby Powder Cancer Claims appeared first on New York Times.